Certara (CERT) SEC Filings: History & Chart

Certara, Inc.(CERT)

Medical - Healthcare Information Services · Radnor, PA

$9.56-0.51 (-5.04%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

About Certara, Inc.

Certara, Inc. provides advanced software solutions and technology-driven services, specializing in biosimulation throughout the entire drug development lifecycle. From initial drug discovery and preclinical research to clinical trials, regulatory submissions, and market entry, the company's core mission is to accelerate the delivery of new medicines to patients by transforming these processes with its innovative biosimulation software and expertise. Its extensive portfolio of technology-enabled services includes mechanistic and empirical biosimulation, strategic guidance for drug development and regulatory affairs, clinical pharmacology, model-based meta-analysis, specialized regulatory writing and medical communications, regulatory operations support, and market access consultation. Furthermore, Certara offers a robust suite of software platforms covering mechanistic and empirical PK/PD biosimulation, data standardization and compliance, scientific informatics, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions, and market access communication. The company's clientele primarily comprises biopharmaceutical firms, academic institutions, and governmental organizations. Established in 2008 and headquartered in Princeton, New Jersey, Certara maintains a significant global presence, with operations spanning numerous countries including the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China.

Radnor, PA

1,546 employees

www.certara.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Jon Resnick

View full financials

Form	Filing Date	Accepted	Document
4	Sep 2, 2026	Sep 2, 2026	View filing
8-K	Aug 7, 2026	Aug 7, 2026	View filing
10-Q	Aug 4, 2026	Aug 4, 2026	View filing
8-K	Aug 4, 2026	Aug 4, 2026	View filing
8-K	Aug 4, 2026	Aug 4, 2026	View filing
3	Jul 17, 2026	Jul 17, 2026	View filing
SC 13G/A	Jul 14, 2026	Jul 14, 2026	View filing
SC 13G/A	Jul 8, 2026	Jul 8, 2026	View filing
8-K	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
4	Jun 2, 2026	Jun 2, 2026	View filing
8-K	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 15, 2026	May 15, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
10-Q	May 11, 2026	May 11, 2026	View filing
8-K	May 11, 2026	May 11, 2026	View filing
D	Apr 28, 2026	Apr 28, 2026	View filing
8-K	Apr 22, 2026	Apr 22, 2026	View filing

SEC Filings

Recent Filings